Potential for Hypoglycemia: Although less common when used alone, semaglutide can cause hypoglycemia (low blood sugar) when used with other glucose-lowering medications, such as insulin or sulfonylureas
A team from Maccabi Health Services retrospectively analysed data on the use of semaglutide in 200,000 patients from the Maccabi diabetes registry
2026 Ozempic Gastroparesis Lawsuit Update Following recent studies and case reports linking Ozempic and gastrointestinal problems, individuals are now seeking compensation through an Ozempic lawsuit over the manufacturers failure to warn about the side effects of the GLP-1 receptor agonist drugs
FDA-Approved Branded Medications Leading the way in semaglutide-based treatments are several FDA-approved branded medications, each with specific indications: Ozempic (semaglutide injection): Primarily FDA-approved for improving blood sugar control in adults with type 2 diabetes, Ozempic also has the significant benefit of reducing the risk of major cardiovascular events in adults with type 2 diabetes and established heart disease
Intended to meet specific patient needs, not for large-scale production
Wegovy (semaglutide) Patient Information Leaflet Official prescribing and patient guidance for Wegovy, including titration schedule and side effects Electronic Medicines Compendium (emc) 3
